Top Midday Stories: JPMorgan Shares Rise Despite Q3 Miss; J&J EPS Guidance Undershoots Estimates, Shares Fall

12:00 PM EDT, 10/13/2026 (MT Newswires) -- All three major US stock indexes were down in late-morning trading Tuesday, as the big banks kicked off earning season earlier in the morning. In company news, JPMorgan Chase (JPM) reported Q3 earnings Tuesday of $5.57 per diluted share, up from $5.07 a year earlier but below the FactSet consensus analyst estimate of $5.93. Third-quarter net revenue was $50.17 billion, up from $46.43 billion a year ago but below the FactSet consensus of $51.23 billion. For Q4, JPMorgan expects net interest income of around $28 billion, above the FactSet consensus of $27.42 billion. For 2026, the bank expects net interest income of $106.2 billion, up from its previous guidance of $105.5 billion and above the FactSet consensus of $105.36 billion. JPMorgan shares were up 1.0% around midday. Johnson & Johnson (JNJ) reported fiscal Q3 adjusted EPS Tuesday of $2.59, down from $2.80 a year earlier but above the FactSet consensus of $2.52. Reported Q3 sales were $25.40 billion, up from $23.99 billion a year ago and above the FactSet consensus of $25.38 billion. For fiscal 2026, the company expects adjusted EPS of $11.05 to $11.15, up from its previous guidance of $10.96 to $11.11 but below the FactSet consensus of $11.19. Fiscal 2026 sales are expected to be between $101.0 billion and $101.4 billion, revised from its previous guidance of $100.8 billion to $101.4 billion and compared with the FactSet consensus of $101.33 billion. Additionally, Chief Executive Joe Wolk told CNBC in an interview the company is targeting mid-2027 for the spinoff of its orthopedics unit DePuy Synthes. Johnson & Johnson shares were down 5.6%. UnitedHealth Group (UNH) reported Q3 adjusted EPS of $4.69, up from $2.92 a year earlier and above the FactSet consensus of $4.14. Third-quarter revenue was $112.69 billion, down from $113.16 billion a year ago but above the FactSet consensus of $111.31 billion. For 2026, the company expects adjusted EPS of at least $20.50, up from its prior guidance of $19.50 to $20 and above the FactSet consensus of $19.80. UnitedHealth shares were down 0.6%. Goldman Sachs (GS) reported Q3 EPS Tuesday of $17.01, up from $12.25 a year earlier and above the FactSet consensus of $12.86. Net revenue was $18.68 billion, up from $15.18 billion a year ago and above the FactSet consensus of $16.83 billion. Goldman shares were up 0.5%. Wells Fargo (WFC) reported Q3 earnings Tuesday of $1.87 per diluted share, up from $1.66 a year earlier and above the FactSet consensus of $1.85. Third-quarter revenue was $21.87 billion, up from $21.44 billion a year ago but below the FactSet consensus of $22.31 billion. For Q4, the company expects net interest income of about $13 billion, above the FactSet consensus of $12.86 billion. Wells Fargo shares were down 1.2%. Citigroup (C) reported Q3 EPS Tuesday of $2.85, up from $1.86 a year earlier and above the FactSet consensus of $2.65. Third-quarter revenue was $23.85 billion, up from $22.08 billion a year ago and above the FactSet consensus of $23.72 billion. Citigroup shares were down 2.3%. Bumble (BMBL) said Tuesday it has entered into a definitive agreement to be acquired by Ithaca Holdings in an all-cash deal valuing the dating app at $1.3 billion. Under the terms of the agreement, Bumble shareholders will receive $6.05 per share of Class A common stock, representing a premium of about 138% to the unaffected closing price of its shares on Oct. 9. Bumble shares were up 56.2%. Anthropic plans to reveal its Q3 financials for the first time on Wednesday at a meeting with potential investors, as it prepares for its initial public offering, CNBC reported Tuesday, citing two people familiar with the matter. Price: 338.04, Change: +3.74, Percent Change: +1.12